We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+15.63%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$925M
AUM Growth
+$121M
Cap. Flow
-$1.06M
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$6.4M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.73M
3
CVS icon
CVS Health
CVS
+$2.43M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
V icon
Visa
V
+$1.6M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.75M
2
CELG
Celgene Corp
CELG
+$5.4M
3
AL
Air Lease Corp
AL
+$2.84M
4
AMT icon
American Tower
AMT
+$1.93M
5
KMI icon
Kinder Morgan
KMI
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.36%
3 Industrials 11.15%
4 Consumer Staples 8.91%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGT icon
126
Target
TGT
$68B
$1.4M 0.15%
17,445
-700
-4% -$51.2K
MOTI icon
127
VanEck Morningstar International Moat ETF
MOTI
$76.9M
$1.4M 0.15%
44,725
+7,315
+20% +$225K
RTX icon
128
RTX Corp
RTX
$301B
$1.38M 0.15%
17,007
-4,897
-22% -$372K
K
129
DELISTED
Kellanova
K
$1.36M 0.15%
25,235
– –
IWM icon
130
iShares Russell 2000 ETF
IWM
$83B
$1.31M 0.14%
8,581
– –
QCOM icon
131
Qualcomm
QCOM
$176B
$1.29M 0.14%
22,568
– –
VNQ icon
132
Vanguard Real Estate ETF
VNQ
$39B
$1.27M 0.14%
14,616
-191
-1% -$15.8K
LLY icon
133
Eli Lilly
LLY
$1.06T
$1.27M 0.14%
9,765
-50
-0.5% -$6.08K
STX icon
134
Seagate
STX
$184B
$1.25M 0.13%
26,000
– –
FTV icon
135
Fortive
FTV
$18.6B
$1.19M 0.13%
22,577
-4,678
-17% -$228K
HON icon
136
Honeywell
HON
$78B
$1.13M 0.12%
7,562
-520
-6% -$72.7K
ICUI icon
137
ICU Medical
ICUI
$4.61B
$1.08M 0.12%
4,500
– –
WOLF icon
138
Wolfspeed
WOLF
$1.71B
$1.06M 0.11%
18,500
– –
VV icon
139
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$1.05M 0.11%
8,122
-19
-0.2% -$2.38K
GPC icon
140
Genuine Parts
GPC
$18.7B
$1.03M 0.11%
9,166
– –
RDS.A
141
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.02M 0.11%
16,323
+50
+0.3% +$3.09K
IWO icon
142
iShares Russell 2000 Growth ETF
IWO
$15.1B
$1M 0.11%
5,100
– –
IWC icon
143
iShares Micro-Cap ETF
IWC
$1.52B
$962K 0.1%
10,373
-265
-2% -$24.4K
COST icon
144
Costco
COST
$420B
$948K 0.1%
3,915
+170
+5% +$37.2K
IVV icon
145
iShares Core S&P 500 ETF
IVV
$902B
$917K 0.1%
3,222
+753
+30% +$206K
BRK.A icon
146
Berkshire Hathaway Class A
BRK.A
$1.12T
$904K 0.1%
3
– –
COP icon
147
ConocoPhillips
COP
$141B
$876K 0.09%
13,130
– –
SEDG icon
148
SolarEdge
SEDG
$1.95B
$871K 0.09%
23,120
– –
SWK icon
149
Stanley Black & Decker
SWK
$15.7B
$871K 0.09%
6,393
-280
-4% -$36.5K
VO icon
150
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$857K 0.09%
21,320
+40
+0.2% +$1.54K
4 5
6
7 8

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Family Office held 255 positions worth $925M, up 15% from $804M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.7%. Boston Family Office opened 7 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q1 2019 buy was Enanta Pharmaceuticals: 2,750 shares worth $263K.
  • Boston Family Office added most to Air Products & Chemicals in Q1 2019, an estimated $6.4M increase.
  • Boston Family Office's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $5.4M.
  • Boston Family Office fully exited Linde in Q1 2019, selling an estimated $7.75M.
  • Boston Family Office's ten largest holdings make up 22% of its $925M portfolio in Q1 2019.
  • Boston Family Office opened 7 new positions and closed 5 in Q1 2019.
  • Boston Family Office's portfolio value rose 15% quarter-over-quarter to $925M.

Based on Boston Family Office's 13F filing for Q1 2019, filed 9 May 2019.